|
Name |
5-Methylmellein
|
Molecular Formula | C11H12O3 | |
IUPAC Name* |
(3R)-8-hydroxy-3,5-dimethyl-3,4-dihydroisochromen-1-one
|
|
SMILES |
C[C@@H]1CC2=C(C=CC(=C2C(=O)O1)O)C
|
|
InChI |
InChI=1S/C11H12O3/c1-6-3-4-9(12)10-8(6)5-7(2)14-11(10)13/h3-4,7,12H,5H2,1-2H3/t7-/m1/s1
|
|
InChIKey |
YETSBBYQOFXYGV-SSDOTTSWSA-N
|
|
Synonyms |
5-Methylmellein; 7734-92-1; Mellein, 5-methyl-; (-)-5-Methylmellein; (3R)-5-Methylmellein; 461BW4X8WN; CHEMBL461985; (3R)-8-hydroxy-3,5-dimethyl-3,4-dihydroisochromen-1-one; (R)-8-hydroxy-3,5-dimethylisochroman-1-one; 1H-2-Benzopyran-1-one, 3,4-dihydro-8-hydroxy-3,5-dimethyl-, (R)-; Isocoumarin, 3,4-dihydro-8-hydroxy-3,5-dimethyl-, (R)-; 1H-2-Benzopyran-1-one, 3,4-dihydro-8-hydroxy-3,5-dimethyl-, (3R)-; 5- Methylochracin; (?)-5-Methylmellein; UNII-461BW4X8WN; DTXSID50564248; BDBM50523994; ZINC13460742; EX-3307; F77577; Q27258884; (3R)-8-Hydroxy-3,5-dimethyl-3,4-dihydro-1H-2-benzopyran-1-one
|
|
CAS | 7734-92-1 | |
PubChem CID | 14807789 | |
ChEMBL ID | CHEMBL461985 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 192.21 | ALogp: | 2.8 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 46.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 14 | QED Weighted: | 0.642 |
Caco-2 Permeability: | -4.546 | MDCK Permeability: | 0.00002700 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.023 |
Blood-Brain-Barrier Penetration (BBB): | 0.473 | Plasma Protein Binding (PPB): | 93.46% |
Volume Distribution (VD): | 0.746 | Fu: | 5.31% |
CYP1A2-inhibitor: | 0.971 | CYP1A2-substrate: | 0.717 |
CYP2C19-inhibitor: | 0.642 | CYP2C19-substrate: | 0.272 |
CYP2C9-inhibitor: | 0.542 | CYP2C9-substrate: | 0.905 |
CYP2D6-inhibitor: | 0.746 | CYP2D6-substrate: | 0.66 |
CYP3A4-inhibitor: | 0.405 | CYP3A4-substrate: | 0.18 |
Clearance (CL): | 12.658 | Half-life (T1/2): | 0.489 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.155 |
Drug-inuced Liver Injury (DILI): | 0.513 | AMES Toxicity: | 0.331 |
Rat Oral Acute Toxicity: | 0.11 | Maximum Recommended Daily Dose: | 0.285 |
Skin Sensitization: | 0.731 | Carcinogencity: | 0.939 |
Eye Corrosion: | 0.18 | Eye Irritation: | 0.963 |
Respiratory Toxicity: | 0.334 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005939 | 0.727 | D04JHN | 0.273 | ||||
ENC001305 | 0.681 | D07MGA | 0.269 | ||||
ENC002310 | 0.681 | D02NSF | 0.266 | ||||
ENC004808 | 0.653 | D0N0OU | 0.255 | ||||
ENC005940 | 0.653 | D06GIP | 0.241 | ||||
ENC005941 | 0.647 | D06XWB | 0.239 | ||||
ENC000584 | 0.574 | D0H6QU | 0.234 | ||||
ENC000856 | 0.574 | D0X3FX | 0.233 | ||||
ENC002082 | 0.574 | D03YVO | 0.231 | ||||
ENC005567 | 0.560 | D03SKD | 0.226 |